Cite
HARVARD Citation
Niss, H. et al. (2022). Evaluation of Continuous Inhaled Epoprostenol in the Treatment of Acute Respiratory Distress Syndrome, Including Patients With SARS-CoV-2 Infection. Annals of pharmacotherapy. 56 (10), pp. 1093-1099. [Online].